Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial.

Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y.

Nutr Cancer. 2008;60(5):643-51. doi: 10.1080/01635580801993280.

PMID:
18791928
2.

Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-γ and/or tumor necrosis factor-α in healthy adults.

Yin Z, Fujii H, Walshe T.

Hum Immunol. 2010 Dec;71(12):1187-90. doi: 10.1016/j.humimm.2010.08.006. Epub 2010 Aug 21.

PMID:
20732368
3.

Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.

Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M.

Oncol Rep. 2005 Jul;14(1):113-20.

PMID:
15944777
4.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z.

Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. Epub 2005 Dec 16.

PMID:
16362410
5.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
6.

Impaired function of circulating dendritic cells in patients with pancreatic cancer.

Yanagimoto H, Takai S, Satoi S, Toyokawa H, Takahashi K, Terakawa N, Kwon AH, Kamiyama Y.

Clin Immunol. 2005 Jan;114(1):52-60.

PMID:
15596409
7.

Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.

Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa M.

Anticancer Drugs. 1998 Apr;9(4):343-50.

PMID:
9635925
9.

GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.

Eksioglu EA, Mahmood SS, Chang M, Reddy V.

Exp Hematol. 2007 Aug;35(8):1163-71. Epub 2007 Jun 11.

PMID:
17562355
10.
11.

A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.

Spierings EL, Fujii H, Sun B, Walshe T.

J Nutr Sci Vitaminol (Tokyo). 2007 Dec;53(6):536-9.

12.
14.
15.

Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).

Reading C, Dowding C, Schramm B, Garsd A, Onizuka-Handa N, Stickney D, Frincke J.

Clin Microbiol Infect. 2006 Nov;12(11):1082-8.

16.

Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model.

Ignacio RM, Kim CS, Kim YD, Lee HM, Qi XF, Kim SK.

Cytokine. 2015 Dec;76(2):131-7. doi: 10.1016/j.cyto.2015.06.002. Epub 2015 Jun 13.

PMID:
26082022
17.

Natural killer-dendritic cell cross-talk in cancer immunotherapy.

Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB.

Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. Review.

PMID:
16197336
18.

[Dendritic cells and tumor specific immunity].

Takahashi H.

Gan To Kagaku Ryoho. 1999 Dec;26(14):2121-6. Review. Japanese.

PMID:
10635293
19.

Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development.

Faries MB, Bedrosian I, Xu S, Koski G, Roros JG, Moise MA, Nguyen HQ, Engels FH, Cohen PA, Czerniecki BJ.

Blood. 2001 Oct 15;98(8):2489-97.

20.

Supplemental Content

Support Center